Join
Live feed
·
PRReleasevia Quantisnow
BeOne Medicines Ltd. logo

BeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

ByQuantisnow·Wall Street's wire, on your screen.
ONC· BeOne Medicines Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONC (BeOne Medicines Ltd.) and more on Quantisnow.